Top Markets
#1 Cortex Cortex +32.71%
#2 EXOD EXOD +9.04%
#3 Seeker Seeker +8.43%
#4 ETHGas ETHGas +7.85%
#5 MarsCoin MarsCoin +7.84%
#6 peaq peaq +7.74%
#7 Official Trump Official Trump +6.67%
#8 Solstice Solstice +5.96%
#9 Ethena Staked ENA Ethena Staked ENA +5.92%
#10 DexNet DexNet +5.76%
Coin of the day
Cortex Cortex
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Classement en actions #6652
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Prix de l'action
$6.02
Dernière synchronisation: 2026-08-27
Capitalisation boursière
$1.93B
Changement (1 jour)
0.00%
Changement (1 an)
112.72%
Pays
US
Échange Taysha Gene Therapies, Inc. (TSHA)

Catégorie

Healthcare
EPS pour Taysha Gene Therapies, Inc. (TSHA)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Taysha Gene Therapies, Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Taysha Gene Therapies, Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH